Reporting
Understanding COVID-19 vaccine confidence in people living with HIV in Canada: A pan-Canadian survey
Learn MoreOngoing
Influence of a 3-month letermovir treatment on gut inflammation in ART-treated HIV-infected persons in an open labelled controlled randomized study
Learn MoreEnrolling
A randomized trial of doxycycline chemoprophylaxis for the prevention of sexually transmitted infections in gay, bisexual and other men who have sex with men (gbMSM)
Learn MoreTerminated
Virtual PrEP: Rendering PrEP delivery more efficient using an mHealth intervention and TAF/FTC
Learn MoreReporting
Vaccines in a Time of Dual Pandemic: COVID-19 Vaccine in People with HIV
Learn MoreEnrolling
The role of fatty liver in the epidemic of advanced chronic liver disease among people living with HIV
Learn MoreOngoing
Drug-drug interaction study between bictegravir/emtricitabine/tenofovir alafenamide and feminizing hormones in trans women living with HIV
Learn MoreStart-up
Development and validation of an anal cancer screening algorithm in HIV-positive men who have sex with men
Learn MoreReporting
A randomized, placebo-controlled trial of oral doxycycline for the prevention of syphilis in HIV-positive men who have sex with men (MSM)
Learn More
CTN Trials have been approved by the Community Advisory Committee of the Canadian HIV Trials Network and the Network’s Scientific Review Committee, or other national peer-review panels such as those at the Canadian Institutes of Health Research and the U.S. National Institutes of Health. CTNPT studies are small-scale investigations designed to determine the feasibility of research concepts, and do not all go through the regular CTN clinical trial review process. For information on the benefits and risks of participating in HIV clinical trials, call CATIE toll-free at 1-800-263-1638.
